Hurley Capital
BSX icon

Hurley Capital’s Boston Scientific BSX Stock Holding History

Hurley Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$19.4K Hold
445
– – 0.01% 283
2026
Q2 		$19K Hold
445
– – 0.01% 276
2026
Q1 		$27.9K Sell
445
-100
-18% -$8K 0.02% 225
2025
Q4 		$52K Buy
545
+100
+22% +$9.8K 0.03% 170
2025
Q3 		$43.4K Sell
445
-49
-10% -$5.07K 0.02% 209
2025
Q2 		$53.1K Hold
494
– – 0.04% 152
2025
Q1 		$49.8K Hold
494
– – 0.04% 170
2024
Q4 		$44.8K Buy
+494
New +$43.5K 0.04% 155

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Hurley Capital's BSX Position: Q3 2026 in Review

Hurley Capital held its Boston Scientific (BSX) position steady in Q3 2026 at 445 shares worth $19.4K. The position accounts for 0.01% of the portfolio, ranked #283.

Hurley Capital first reported a position in BSX in Q4 2024 and has held it in 8 quarters since. The position peaked at $53.1K in Q2 2025. 922 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Hurley Capital held 445 shares of Boston Scientific worth $19.4K as of Q3 2026.
  • Hurley Capital left its Boston Scientific share count unchanged in Q3 2026.
  • Boston Scientific made up 0.01% of Hurley Capital's portfolio in Q3 2026, its #283 holding.
  • Hurley Capital first reported a position in Boston Scientific in Q4 2024 and has held it in 8 quarters since.
  • Hurley Capital's Boston Scientific position peaked at $53.1K in Q2 2025.
  • 922 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Hurley Capital's 13F filing for Q3 2026, filed 5 Nov 2026.